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The hematopoietic system is an invaluable model both for understanding basic developmental biology and for
developing clinically relevant cell therapies. Using highly purified cells and rigorous microarray analysis we have
compared the expression pattern of three of the most primitive hematopoietic subpopulations in adult mouse bone
marrow: long-term hematopoietic stem cells (HSC), short-term HSC, and multipotent progenitors. All three populations
are capable of differentiating into a spectrum of mature blood cells, but differ in their self-renewal and proliferative
capacity. We identified numerous novel potential regulators of HSC self-renewal and proliferation that were
differentially expressed between these closely related cell populations. Many of the differentially expressed transcripts
fit into pathways and protein complexes not previously identified in HSC, providing evidence for new HSC regulatory
units. Extending these observations to the protein level, we demonstrate expression of several of the corresponding
proteins, which provide novel surface markers for HSC. We discuss the implications of our findings for HSC biology. In
particular, our data suggest that cell–cell and cell–matrix interactions are major regulators of long-term HSC, and that
HSC themselves play important roles in regulating their immediate microenvironment.
Citation: Forsberg EC, Prohaska SS, Katzman S, Heffner GC, Stuart JM, et al. (2005) Differential expression of novel potential regulators in hematopoietic stem cells. PLoS
Genet 1(3): e28.
Introduction
Mature blood cells have a high turnover rate and need to be
constantly replaced as well as respond to more acute
conditions such as blood loss or infections, requiring the
rapid generation of millions of new blood cells. This demand
is fulﬁlled for life by a pool of hematopoietic stem cells (HSC).
The long-term repopulating HSC (LT-HSC) thus has to be
capable of differentiating without depleting the stem cell
pool, thereby satisfying the deﬁnition of a stem cell: the
ability at the single cell level to both self-renew and
differentiate into more mature cell types. LT-HSC normally
reside in the bone marrow and have essentially six devel-
opmental choices: remain quiescent, differentiate, self-renew,
migrate, enter senescence, or undergo apoptosis. Such fate
decisions are likely controlled both by HSC-intrinsic mech-
anisms and by the bone marrow microenvironment or
‘‘niche.’’ It has proved difﬁcult to deﬁne the complex intrinsic
and extrinsic mechanisms that govern the balance of these
decisions. In hematopoiesis, only LT-HSC are capable of
lifelong self-renewal and, therefore, is the operative popula-
tion in hematopoietic transplantation. Understanding how
HSC fate decisions are controlled is therefore of critical
importance.
The expression proﬁles of primitive hematopoietic cells
deﬁned by various criteria have previously been compared
to other hematopoietic and non-hematopoietic cell types
[1–5]. In addition, several molecules and pathways have been
implicated in HSC self-renewal, including HoxB4, Bmi1, the
Wnt/b-catenin signaling pathway, and Notch [6–9]. As the
bone marrow microenvironment likely provides unique cues
necessary for proper HSC function, cell surface proteins
mediating these signals should play important roles in HSC
fate decisions. While there have been recent advances in
deﬁning a potential HSC niche within the bone marrow
[10,11], little is known about the speciﬁc signals regulating
HSC in vivo. A central question is how the interplay of
soluble ligands, matrix interactions, and cell–cell contacts
inﬂuence HSC fate. Recent evidence points to a role for the
angiopoietin receptor Tek, also known as Tie2, in main-
taining transplantable HSC [12]. Likewise, HSC in mice null
for Mmp9, a matrix metalloproteinase (Mmp) that facilitates
cell migration by proteolytic cleavage, have impaired
proliferation and differentiation capabilities [13]. In addi-
tion, mice lacking integrin b1, part of the HSC homing
receptor a4b1 [14], cannot establish fetal liver hematopoiesis
[15], presumably due to a failure of LT-HSC to engraft at
this fetal site. Thus, there is increasing evidence that
interactions with the environment are important for the
maintenance of HSC self-renewal capability. A thorough
understanding of cell surface molecules expressed on HSC is
an important step in identifying functional interactions with
the environment.
Here, we have carefully analyzed the transcription proﬁles
of three highly puriﬁed subpopulations within the mouse
adult bone marrow lineage
 /c-kit
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lo/Flk2
  KLS), short-term (ST)-HSC
(Thy1.1
lo/Flk2
þ KLS), and multipotent progenitors (MPP)
(Thy1.1
 /Flk2
þ KLS) [16]. These three populations have the
ability to give rise to both lymphoid and myeloid lineages [16]
and platelets (E. C. F., E. Passegue ´, and I. L. W., unpublished
data) when transplanted into irradiated mice. Thus, LT-HSC,
ST-HSC and MPP have similar multilineage potential, but
differ in their self-renewal and proliferative capacity. All
long-term repopulating activity is contained in the LT-HSC
fraction; thus, cells within this fraction are the only cells
capable of maintaining hematopoiesis for the life of the host.
As LT-HSC differentiate to ST-HSC and then to MPP, self-
renewal capability progressively declines [16]. Therefore, cells
derived from transplanted ST-HSC and MPP decrease to
undetectable levels in peripheral blood by about ten weeks
posttransplant. LT-HSC, ST-HSC and MPP also differ in their
cell cycle status. While most LT-HSC are quiescent, a larger
fraction of ST-HSC and MPP are in cycle under steady-state
conditions (E. Passegue ´, A. J. Wagers, and I. L. W.,
unpublished data). Based on these small, but functionally
critical differences, we reasoned that comparing the tran-
scriptional proﬁle of these three populations would reveal
genes speciﬁcally involved in self-renewal, quiescence, and
proliferation mechanisms. Here, we present new data on
selective gene expression in highly puriﬁed HSC subsets and
discuss the possible implications for HSC biology.
Results
Experimental Design and Data Analysis
To obtain accurate and reliable transcription proﬁles of
LT-HSC, ST-HSC and MPP, we isolated highly pure, func-
tionally deﬁned cell populations and performed pairwise
competitive hybridizations in three independent experi-
ments, each with a ‘‘dye swap,’’ so that each comparison was
performed six times. This allowed us to identify small but
reproducible changes in gene expression. We used Stanford
microarrays spotted with about 42,000 cDNAs and expressed
sequence tags (ESTs) from a wide variety of tissue- and
developmental stage-speciﬁc libraries, including a library
made from bone marrow-subtracted HSC cDNA [4] and a
selection of genes involved in development and hematopoi-
esis. We employed stringent criteria when evaluating and
scoring genes as differentially expressed. This resulted in six
gene lists (two for each comparison; Figure 1 and Tables
S1 S6). As expected, most of the differentially regulated
transcripts came from the comparison of LT-HSC to MPP,
with 527 transcripts upregulated in LT-HSC and 323 tran-
scripts upregulated in MPP, totaling 850 differentially
regulated transcripts. Between LT-HSC and ST-HSC 565
transcripts were differentially regulated, as were 111 tran-
scripts between ST-HSC and MPP (Table 1). The top 25
statistically signiﬁcant up- and downregulated genes from
each comparison are listed in Figure 1. Complete lists of all
differentially regulated genes, including ESTs and transcripts
represented by multiple spots, are presented in Tables S1 S6
and summarized as a heat map representation in Figure 2.
The reliability of the resulting lists of differentially
expressed genes was then assessed in several ways. First, as
illustrated in Figure 2, the reproducibility between and across
arrays is extremely good and consistent with the previously
described linear relationship between these populations,
where LT-HSC give rise to, ﬁrst, ST-HSC, which in turn
differentiate into MPP. Second, these data accurately reﬂect
the expression of several transcripts known to be differ-
entially expressed in hematopoietic stem and progenitor
cells. These include the sort markers Thy1.1 (upregulated in
LT-HSC) and Flk2 (upregulated in MPP). The transporter
Abcg2, responsible for the ‘‘side population’’ phenotype [17],
is upregulated in LT-HSC, while CD34 transcripts increase
with differentiation, consistent with CD34 protein levels in
previous studies [18]. A fraction of LT-HSC is negative for
CD34 cell surface protein, while the vast majority of ST-HSC
and MPP are CD34-positive (Figure 3). Aldehyde dehydrogen-
ase, Aldh1a1, and Tek transcript levels are also higher in LT-
HSC in agreement with their selective expression by HSC
reported previously [12,19,20]. In addition, numerous tran-
scripts scored consistent with each other on the Stanford
cDNA arrays if represented by two or more spots, and when
assayed using Agilent oligonucleotide arrays (see Figure 1;
unpublished data). We also conﬁrmed the expression patterns
of several of the transcripts by quantitative RT-PCR of
unampliﬁed RNA from double-sorted cells (Figure S1) and by
ﬂow cytometry of protein levels (Figure 3). In no case did RT-
PCR or cell surface protein levels contradict the array data.
Thus, we believe that these analyses accurately reﬂect the true
transcription proﬁle of these three populations.
To detect potential self-renewal or proliferation loci we
determined the chromosomal location of genes differentially
Figure 1. Top 25 Differentially Regulated Transcripts with Corresponding SAM Plots for Each Comparison
Only known, unique genes are listed; thus, ESTs were removed, and genes appearing more than once in the same list are denoted with number of
appearances in parentheses. An ‘‘A’’ in parenthesis indicates that results from analogous experiments using Agilent arrays are consistent with the
Stanford Microarray Database array data. The LT-HSC to ST-HSC comparison was not performed with Agilent arrays.
DOI: 10.1371/journal.pgen.0010028.g001
Synopsis
Hematopoietic, or blood-forming, stem cells (HSC) are responsible
for the continual replenishment of all blood cells throughout life.
This ability to both renew themselves and give rise to expanded
populations of differentiating and mature cells is a hallmark of stem
cells and is therefore an area of intense research. The rarity of HSC as
well as their location in the bone marrow environment has made it
difficult to identify the genes that regulate these properties. The
earliest stages of blood development begins with the long-term (LT)
repopulating HSC that then differentiate into short-term (ST)
repopulating HSC and non-self renewing multipotent progenitors
(MPP). The authors investigated the gene expression differences in
these highly purified populations that differ mainly in their capacity
to self renew, and identified a number of genes specific to each of
these populations. Intriguingly, many of these genes code for
proteins that are involved in cell–cell and cell–matrix interactions
that were not previously identified on these populations. These
novel discoveries will, together with future experiments, enhance
our understanding of the basic biology of stem cells and their
clinical uses.
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Novel Hematopoietic Stem Cell Regulatorsregulated between LT-HSC and MPP (Figure S2). The most
striking difference was observed on the X chromosome,
where 23 genes upregulated in LT-HSC but only one MPP-
speciﬁc gene reside. The highest enrichment of MPP-speciﬁc
genes was a 2.4-fold increase on chromosome 19. The 23 LT-
speciﬁc genes are listed in Table S7. We detected no
enrichment of LT-HSC-speciﬁc genes on chromosome 17,
which we and others previously showed to contain a stem cell
frequency locus [2,21].
To assess objectively what types of genes were differentially
regulated, we used the gene classiﬁcation tool Gene Ontology
(GO) [22]. GO has classiﬁed a large number of genes based on
biological processes, molecular function, and cellular com-
ponent. Genes enriched in the more primitive cells are
overrepresented in the GO categories involving cell junction,
anion transport, extracellular space, and oxidoreductase
activity, whereas cell differentiation enriched for transcripts
in the cell cycle, immune response, taxis/chemotaxis, and
regulation of transcription categories. However, as only a
fraction of the genes in our data set has been classiﬁed by GO,
the majority were broadly categorized by reviewing published
literature and discussed based on cellular location moving
from the extracellular space inward. Genes discussed in the
text are summarized in Table 2 and selected transcripts are
depicted in Figure 4. Additional references are presented in
Table S8.
Extracellular Matrix and Other Secreted Proteins
The extracellular matrix (ECM) proteins upregulated in
LT-HSC include transglutaminase2 (Tgm2), biglycan, Dag1/
dystroglycan, ApoE, Emilin1, Calsyntenin1, collagens type 4a1
and 4a2, and the heparin-binding protein Fstl1. Tgm2 is a
widely expressed protein cross-linking enzyme that can
function in the ECM, cytosol, and nucleus. The proteoglycan
biglycan is highly expressed in connective tissues including
bone, and mice lacking biglycan are prone to osteoporosis.
ApoE, an ECM protein and a component of low-density
lipoproteins, interacts directly with biglycan, and both ApoE
and biglycan bind to membrane proteins preferentially
expressed by LT-HSC (see below). By expressing genes
encoding structural components of the ECM such as collagens
and proteoglycans, LT-HSC may contribute to the architec-
ture of its immediate microenvironment. In contrast, matrix
metalloproteinases (Mmp) facilitate cell motility and are
important for HSC differentiation [13]. Mmp15 and Mmp16
are upregulated in LT-HSC, but their activity may be
inhibited by high levels of the Mmp inhibitors Timp2 and
Timp3. Interestingly, concurrent with Timp2 downregulation
in MPP, the main target of Timp2, Mmp2, is upregulated.
Another facilitator of cell motility, heparanase, is also
upregulated in MPP. Heparan sulfate-bearing membrane
receptors, potential substrates for heparanase, are upregu-
lated in LT-HSC (below). Together, the increases in hepar-
anase and Mmp2 expression and decreases in Timp2 and
Timp3 levels may act to destabilize cell interactions with the
matrix and allow a subset of HSC to exit the niche and
undergo differentiation.
Membrane, Cell Junction, and Adhesion Molecules
The ‘‘cell junction’’ GO category includes a number of
genes not previously implicated in HSC biology. Transcripts
upregulated in LT-HSC in this category include the junction
adhesion molecules Jam1/F11R, Jam2 and Jam3, Claudin12,
Claudin22, the tight junction protein Tjp1/ZO-1, and the
connexins Gja1 and Gjb5. Jam2 protein is detectable on the
surface of LT-HSC, and its levels decrease as LT-HSC
differentiate into ST-HSC and MPP (see Figure 3). Jams,
Tjps, and claudins commonly colocalize in epithelial cells to
form tight junctions. Tjp1 is also found at gap junctions with
the channel-forming connexins. The differential expression
of two connexins in LT-HSC, Gja1 and Gjb5, is consistent
with evidence for gap junctions functioning in stem cell
regulation in human ES cells [23], and in Drosophila, where the
gap junction protein Zpg is necessary for proper germ stem
cell differentiation [24]. It will be interesting to determine
whether these proteins form functional channels in HSC, and
if so, with what partner cells and what types of molecules are
exchanged between cells.
VCAM1 and ESAM1 are related adhesion molecules
upregulated in LT-HSC both at the transcript and protein
level (see Figure 3). VCAM1 interaction with integrin a4b1
mediates cell–cell interactions in multiple cell types, and both
VCAM1 and integrin a4b1 have been implicated in HSC
homing to the bone marrow. As at least a subset of LT-HSC
express a4b1 [14], detection of VCAM1 protein on all LT-
HSC (Figure 3) indicates that a single LT-HSC can express
both a4b1 and VCAM1. ESAM1 was ﬁrst described on
endothelial cells, but is also expressed on megakaryocytes
and platelets [25,26]. ESAM1 mediates homophilic interac-
tions between endothelial cells and colocalizes with tight
junction proteins and claudins. The self-ligand Slamf1,
known for its roles in bidirectional T- and B-cell stimulation,
is upregulated in LT-HSC, as shown here and in other studies
(S. Morrison, personal communication). Interestingly, the cell
Table 1. Summary of the Numbers of Differentially Regulated Transcripts
Cell Populations Compared LTvST LTvMPP STvMPP
Spots on array 42,025 42,025 42,025
Spots with more than five data points 22,437 24,269 25,130
Differentially regulated spots 633 968 133
Fold change 1.3–5.7 1.4–16.7 1.6–6.5
Differentially regulated spots
a 220 413 606 362 108 25
Differentially regulated transcripts
a 199 366 527 323 89 22
Listed are comparisons between LT-HSC, ST-HSC, and MPP before and after filtering for statistical significance and spots representing the same gene.
aColor-coded numbers correspond to the color coding of the stem cell type in the column header.
DOI: 10.1371/journal.pgen.0010028.t001
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and negative fractions, whereas ST-HSC and MPP are
uniformly Slamf1 negative (Figure 3). As HSC negative for
CD34 are Slamf1 positive, and there is an inverse relationship
between Slamf1 and Flk2 surface expression on both HSC
and myeloid progenitor populations, Slamf1 functions as a
useful marker to separate these populations (D. Bryder, E. C.
F., and I. L. W., unpublished data). Ongoing studies indicate
that there are functional differences between Slamf1 positive
and negative stem and progenitor populations.
LT-HSC also express higher levels of the receptor Robo4,
its putative ligand Slit-like2, and the effector protein Srgap2
than do ST-HSC or MPP. In Drosophila, Slit/Roundabout
signaling promotes asymmetric division, and it inhibits cell
migration in both Drosophila and mammalian systems [27,28],
perhaps by inhibition of Mmp2 and Mmp9 by Slit [29]. Robo4
can interact directly with DCC, a homolog of Neogenin which
Figure 2. Heat Map Representation of Differentially Regulated Tran-
scripts
Rows represent genes and columns represent array comparisons
between cell populations as indicated.
(A) Significance score by SAM is indicated from top to bottom of each
comparison (n¼6) by gradients of yellow or blue, with brighter yellow or
blue indicating higher significance. Yellow or blue in additional columns
indicate that the gene was also differentially expressed between these
cell types (e.g., many of the genes upregulated in MPP versus LT-HSC
were also upregulated in ST-HSC compared to LT-HSC).
(B) Conventional red-green expression data for all the differentially
regulated genes for each array. Red indicates genes upregulated in the
more differentiated cell population (e.g., upregulated in MPP when
compared to LT-HSC); green indicates upregulated in the less differ-
entiated cell population.
DOI: 10.1371/journal.pgen.0010028.g002
Figure 3. Flow Cytometric Analysis of Cell Surface Protein Levels on LT-
HSC, ST-HSC, and MPP Relative to Control
Green represents LT-HSC, blue represents ST-HSC, red represents MPP,
and grey represents the control.
DOI: 10.1371/journal.pgen.0010028.g003
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Novel Hematopoietic Stem Cell Regulatorsis also upregulated in LT-HSC over MPP. In other systems,
Neogenin and DCC are implicated in cell adhesion, polarity,
and migration, and are receptors for the Netrin family of
chemoattractants. Interestingly, Slit and Netrin signaling
inﬂuence each other [30] and can have opposing effects
[31]. Slit signaling can also modulate Cxcr4-mediated chemo-
taxis [29], and may therefore play a role in HSC migration
toward Sdf1 gradients [32,33].
Drosophila Roundabout binds directly to Syndecan [27], and
Roundabout mutants phenocopy the Syndecan mutant [34].
Table 2. Differentially Regulated Transcripts Discussed in the Text
Location LT-HSC ST-HSC/MPP
Extracellular Angpt1, ApoE, Bgn, Col4a1, Col4a2, Dag1, Fstl1,
Mmp15, Mmp16, Slitl2, Timp2, Timp3, Tgm2
Ccl3, Ccl4, Ccl9, Hpse, Il1b, Mmp2
Membrane Abcg2, Aldh1a1, Aldh7a1, App, CD63, CD9, Cldn12, Cldn22,
Esam1, Gja1, Gjb5, Itga6, Jam1, Jam2, Jam3, Map17, Mllt4,
Neo1, Robo4, Sdc2, Sgce, Slamf1, Tek, Thy1.1, Tjp1, Vcam1
Blnk, Ccr5, CD34, Igh6, Il1r1, Il17r, Il10ra, Il10rb,
Mpeg1, Notch1, Sdc1
Intracellular Cat, Cyp2j6, Cttn, Epb4.1, Fgd1, Grb2,
Grb10, Gsta1, Gstk1, Gstm1, Srgap2
Gsn, Lims1
Proliferation Ccnd3, Cdkn1c, Ches1, Ndn, p53, Sesn1, Smc1l1 Ccna2, Ccnb1, Ccnb2, Ccnd1, Cenpe, Cenph, Ier5, Kif4,
Kifc5a, Kif22, Kif23, Mki67, Mlp, Smc2l1, Smc4l1, Spag5, Top2a
Nuclear Dach1, Eya2, Gata1, Gata2, Hmgb3, Hoxa5, Hoxb5,
Mllt3, Nfe2, Pbx1, Pbx3, Rex3, Ski, Sox6, Sox18
Atrx, c-myc, Ddx4, Hoxa9, Notch1, Satb1, Tcf12
DOI: 10.1371/journal.pgen.0010028.t002
Figure 4. Hypothetical Model of Selected Potential Interactions of Proteins Corresponding to Differentially Expressed Transcripts
Molecules upregulated in LT-HSC are in green; those upregulated in MPP are red. Depicted protein interactions and colocalization are based on
published reports in various mammalian and nonmammalian systems. Single cells expressing all the proteins as depicted in this cartoon may not exist.
Not drawn to scale.
DOI: 10.1371/journal.pgen.0010028.g004
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Novel Hematopoietic Stem Cell RegulatorsThe syndecans are transmembrane heparan sulfate-decorated
molecules that link the cytoskeleton to the extracellular space
and participate in cell–cell and cell–matrix interactions, cell
proliferation, and growth factor signaling. We found Sdc1
transcripts upregulated in MPP, and a fraction of MPP also
expresses the protein on the cell surface (Figure 3). In
contrast, Sdc2 transcripts are enriched in LT-HSC. Both Sdc1
and Sdc2 are coreceptors for FGF and GM-CSF [35,36],
molecules with known functions in hematopoiesis. Syndecan-
mediated adhesion is regulated by metalloproteinases and
their inhibitors as well as by heparanase. Cleavage of the
heparin chains by heparanase or proteolysis by metallopro-
teinases increases cell migration, the latter of which can be
inhibited by Mmp inhibitors such as Timp3 [27]. Thus,
differential expression of syndecans and regulation of their
cell–cell and cell–matrix interactions may control retention
versus release of cells from the niche.
Amyloid beta precursor protein (App) is a heparin-binding
cell adhesion molecule that interacts with two of the
extracellular matrix molecules upregulated in LT-HSC, ApoE
[37] and biglycan [38]. Mutations of App have been implicated
in Alzheimer’s disease. Proteolytic cleavage of App by c-
secretase and presenilin leads to nuclear translocation and
transcriptional activation. App may thus directly transmit
extracellular signals to regulate transcription of speciﬁc target
genes in LT-HSC.
Tek is expressed by HSC [12,19], and a role for Tek in
maintaining HSC quiescence through interaction with the
niche was suggested [12]. Tek transcript levels are indeed
higher in LT-HSC than in ST-HSC or MPP, and all detectable
cell surface expression of Tek protein is contained within the
LT-HSC fraction (Figure 3). We and others [1] also detected
robust and differential transcript levels of the Tek ligand
angiopoietin1 in LT-HSC, suggesting potential autocrine or
paracrine Tek activation.
Several other proteins corresponding to transcripts
enriched in LT-HSC might mediate cell–cell and cell–matrix
interactions. Map17 is expressed mainly in the kidney but is
also enriched in LT-HSC over MPP. Although upregulated in
carcinomas, overexpression of Map17 in colon carcinoma
cells can inhibit cell proliferation and tumor growth [39]. The
tetraspanins CD9 and CD63 can function as metastasis
suppressors, potentially due to association with integrins
[40]. The surface protein levels of CD9 correlate with the
transcript proﬁle (Figure 3). Elsewhere we have shown that
CD9 is a marker for the megakaryocyte progenitor, MKP [41].
CD9 can interact with integrin a6 (Itga6) [42–44], which,
together with integrin b1, form a cell surface laminin-binding
receptor. Cell surface expression of Itga6 and Itgb1 on HSC
was demonstrated previously [14]. Itga6 may be a general
stem cell marker since it is upregulated on LT-HSC in
addition to stem cells of several other tissues [45,46]. Another
surface protein upregulated in LT-HSC, Mllt4, is an actin
ﬁlament-binding protein that belongs to a cadherin/catenin
adhesion system with roles in the organization of homotypic
and heterotypic cell–cell adherens junctions [47].
In contrast to the abundance of cell adhesion molecules
upregulated in LT-HSC, MPP express a number of cell
surface receptors implicated in immune response and
chemokine activation. These include IL10ra and b, IL1r1,
IL17r, Mpeg1, Blnk, Notch1, Ccr5, and Igh6. These and other
receptors selectively expressed by MPP can render cells
responsive to chemotactic and inﬂammatory response mol-
ecules such as Ccl3, Ccl4, Ccl9, and IL1b, whose transcripts
are also upregulated in MPP. It is possible that distinct subsets
of MPP express high levels of particular transcripts as an early
indicator of commitment to different downstream lymphoid
and myeloid lineages, or that the presence of both types of
transcripts are indicative of promiscuous expression associ-
ated with lineage commitment [48,49].
Intracellular Adaptor and Signaling Molecules
Links between the extracellular space and the actin
cytoskeleton are provided by several transcripts preferen-
tially expressed by LT-HSC. This includes direct interaction
with actins by transmembrane proteins such as Mllt4 and
sarcoglycan E, as well as by use of adaptor molecules such as
the erythrocyte cell shaping protein Epb4.1, the Slit/Robo
effector protein Srgap2, cortactin, and Fgd1. Cortactin
functions in cell shape, actin organization, and cell adhesion
by interacting directly with actin and with components of
adherens-type junctions, including cadherins, catenins, and
Tjp1 [50]. Cortactin also interacts with Fgd1 [51], a protein
with roles in actin organization and cell shape.
The growth factor receptor-bound adaptor proteins Grb2
and Grb10 are also upregulated in LT-HSC. In other systems,
Grb10 regulates signaling from several receptors, including
IGFR, PDGFR, EGFR, and VEGFR2, at least in part by
antagonizing receptor degradation by Nedd4 [52], a ubiquitin
ligase robustly expressed in HSC. Depending on the context,
Grb10 may promote or inhibit cell growth [53]. Grb2 can
interact with App to regulate apoptosis in a Map kinase-
dependent manner in neuroblastoma cells [54]. Interestingly,
Grb2 also binds catalase [55], an enzyme recently implicated
in HSC self-renewal [56]. Catalase is upregulated in LT-HSC
together with other transcripts implicated in oxidoreductase
activity such as Sestrin1, the known stem cell marker
aldehyde dehydrogenase Aldh1a1 and its homolog Aldh7a1,
the cytochrome P450 Cyp2j6, and glutathione-S-transferases
Gsta1, Gstk1, and Gstm1. These enzymes may render LT-HSC
uniquely resistant to stress, a property that would be
particularly important for long-lived cells such as stem cells.
MPP have higher transcript levels for proteins with
potentially opposite effects of those upregulated in LT-
HSC. Two such examples that regulate cell growth, prolifer-
ation, and differentiation are Gelsolin, a calcium-dependent
actin-depolymerizing protein, and Lims1, an adaptor protein
mediating integrin and growth factor signaling at focal
adhesions [57,58].
Proliferation and Cell Cycle Genes
The proliferative activity of LT-HSC increases as they
differentiate into ST-HSC and MPP (E. Passegue ´, A. J. Wagers,
and I. L. W., unpublished data). Thus, we expected transcripts
related to cell cycle control to be differentially regulated.
Indeed, the most signiﬁcantly enriched GO categories for
MPP are related to cell proliferation. The array data
presented here are corroborated by the qRT-PCR data
performed on the same cell populations (E. Passegue ´, A. J.
Wagers, and I. L. W., unpublished data) and indicate that LT-
HSC express higher levels of cyclin D3 and the cyclin-
dependent kinase inhibitor p57/Cdkn1c, whereas ST-HSC/
MPP express higher levels of cyclins A2, B1, B2, and D1 and
the proliferation marker Ki67. Our array analysis identiﬁed
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regulating HSC cell cycle status. Transcripts enriched in
LT-HSC include p53, the growth suppressor necdin; Sesn1, a
regulator of cell cycle arrest and a negative regulator of cell
proliferation; and Ches1, a probable transcriptional activator
that may be involved in DNA damage-induced cell cycle
arrests.
Ier5, a mediator of mitogenic signals, is upregulated in ST-
HSC and MPP, as are several transcripts associated with
mitotic chromosomes. These include Spag5, the centromere
proteins Cenph and Cenpe, and the kinesins Kif4, Kifc5a,
Kif22, and Kif23. Marcks-like protein (Mlp), a component of
the anaphase-promoting complex, and the topoisomerase
Top2a are also increased. Two cohesin-complex transcripts,
Smc2l1 and Smc4l1, are upregulated as LT-HSC differentiate,
potentially to promote chromosome segregation during the
increased cycling of ST-HSC and MPP. In contrast, Smc1l1 is
upregulated in LT-HSC. Smc1l1 is phosphorylated by ataxia
telangiectasia mutated, indicating a potential role for this
protein in DNA repair. This is also of note, since ataxia
telangiectasia mutated-mediated responses to oxidative stress
recently were implicated in HSC self-renewal [56]. Although
several of the transcripts in this category may be upregulated
as a consequence of increased cycling, some likely have more
causal roles. Proliferation is likely regulated to a signiﬁcant
extent by high expression of cell cycle inhibitors such as p57/
Cdkn1c in LT-HSC. However, of note is that cyclin D3 is
upregulated in LT-HSC, and it will be interesting to
determine whether cyclin D3 activity favors self-renewing
divisions over divisions associated with differentiation.
Transcription Factors and Other Nuclear Proteins
Transcriptional regulators with higher expression in LT-
HSC include the erythroid- and megakaryocyte-speciﬁc
transcription factors Gata1, Gata2, and Nfe2; members of
the Hox family of transcription factors, Hoxa5 and Hoxb5;
the Hox-interacting Pbx1 and Pbx3; the high-mobility group
proteins Sox6, Sox18, and Hmgb3; and Ski, Dachshund1, and
Eya2. Ski and Dachshund belong to the Ski/Sno family of
proto-oncogenes implicated in TGF-b/Smad signaling. They
generally act as corepressors of transcription in concert with
DNA-binding proteins and histone deacetylases. Ski has
previously been shown to be expressed in hematopoietic
cells [59] and to play a role in regulating cell proliferation by
interfering with TGF-b signaling [60] or Myb-mediated
transcriptional activation [61]. Indeed, as transcript levels of
Ski decline in MPP, there is increased expression of the Myb
target gene c-myc. This transcriptional repressor or activator
depending on the context, might affect the balance of HSC
self-renewal, as mice lacking hematopoietic expression of c-
myc have increased numbers of phenotypic HSC and fewer
differentiated progeny [62].
Dachshund proteins operate together with the Eya family
of proteins to regulate gene expression. While Dach can
repress transcription either by binding directly to DNA or as
a corepressor for the Six family of proteins, Eya factors are
transcriptional coactivators [63,64]. Both Eya1 and Eya2
transcripts are enriched in HSC when compared to hema-
topoietic progenitor populations [4], but only Eya2 is differ-
entially expressed among LT-HSC, ST-HSC and MPP. The
Eya proteins interact with G proteins in the cytosol, trans-
locate to the nucleus, and use their phosphatase activity to
regulate transcription [65]. The Eya/Dach complex has been
implicated in modulating precursor cell proliferation [65] by
regulating transcription of cell cycle inhibitors such as p27/
Cdkn1b [63].
The high-mobility group proteins Hmgb3, Sox6, and Sox18
are upregulated in LT-HSC compared to MPP. Sox18 has
been implicated in vascular development and transactivates
the Vcam1 promoter [66], consistent with the higher levels of
Vcam1 in LT-HSC (Figure 3). Sox6 has mainly been
implicated in cartilage formation as a downstream mediator
of Bmp signaling [67], but it can also regulate transcription of
the cell adhesion molecules N- and E-cadherin and of Wnt1
[68]. By affecting these regulators of HSC function, Sox6
could play important roles in HSC biology. However, Sox6
null mice have no obvious hematopoietic phenotype, suggest-
ing the presence of redundant factors or mechanisms. Hmgb3
has previously been shown to be expressed by HSC, and its
downregulation was important for differentiation into
myeloid and lymphoid but not erythroid lineages [69]. The
lower levels of Hmgb3, Gata1, Gata2, and Nfe2 transcripts
may contribute to attenuated erythroid and megakaryocyte
potential of MPP compared to LT-HSC.
Nuclear factors upregulated in MPP include Ddx4, Hoxa9,
Satb1, Atrx, Notch1, and Tcf12. Tcf12 may play a role in the
proliferation of neural stem and progenitor cells [70], and its
upregulation in MPP could indicate a similar role in
hematopoiesis. Hoxa9 and several other Hox genes have
important roles in hematopoiesis, and several Hox members
are involved in chromosomal translocations in leukemo-
genesis. Hoxa9 null mice have signiﬁcant reductions of both
myeloid and lymphoid progenitor populations [71], and
overexpression of Hoxa9 can expand the HSC pool [72],
indicating that Hoxa9 is a regulator of hematopoietic stem
and progenitor cell pool size. The expression of Ddx4, a
homolog of Drosophila Vasa, in MPP is surprising as it has been
shown previously to be selectively expressed in the germline
[73]. Ddx4 has RNA helicase activity and is involved in RNA-
related processes such as translation initiation, splicing, and
nucleosome assembly. Upregulation of Ddx4 in MPP may
reﬂect increased or selective translational activity compared
to LT-HSC.
Although Notch1 has been implicated in HSC self-renewal
[9], transcript levels of Notch1 increase as LT-HSC differ-
entiate to MPP. Notch1, as well as the chromatin-remodeling
protein Satb1, have roles in lymphoid development and cell
fate decisions. Mutations of another chromatin remodeling
factor upregulated in MPP, Atrx, are associated with mental
retardation and a-thalassemia. Atrx may play roles in spindle
organization and chromosome alignment during cell division
[74], in addition to modifying chromatin structure to regulate
transcription. As several transcriptional activators and
repressors have been implicated both in HSC self-renewal
and as master regulators of hematopoiesis, the role of
transcriptional regulators not previously known to be ex-
pressed by HSC, such as Dachshund, will be interesting to
examine, and genes regulated by a potential Dach/Ski/Eya2
complex may play important roles in LT-HSC fate decisions.
Discussion
H e r e ,w eh a v ea n a l y z e di nd e t a i lt h ed i f f e r e n c ei n
transcriptional proﬁles between LT-HSC and two closely
related isolatable progeny during steady-state hematopoiesis.
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known to be expressed by HSC. Directly comparing highly
puriﬁed LT-HSC to closely related progeny as opposed to
heterogeneous cell populations or cells of nonhematopoietic
lineages likely enhanced the sensitivity of the analysis. It is
important to note that our analyses focused on differential
expression and therefore did not seek to identify genes that
are important for HSC biology but are not differentially
expressed at the transcript level among LT-HSC, ST-HSC,
and MPP. Posttranscriptional regulation and interaction with
differentially expressed molecules may regulate the activity of
such proteins. The differentially regulated transcripts we
identiﬁed likely play important roles in early hematopoietic
decisions, including self-renewal and quiescence of LT-HSC,
and differentiation into the more proliferative ST-HSC and
MPP. Collectively, these data support previous evidence
suggesting that processes such as quiescence, adhesion, and
cytoprotection are particularly important for LT-HSC
integrity, while differentiation, proliferation, and chemotaxis
are increasingly important for the immediate progeny
(Figure 5). Novel candidates regulating these processes
provide a model that will guide functional studies.
As shown in Figure 3, our analysis also led to the
identiﬁcation of new differentially expressed cell surface
markers. It is important to note that there are multiple ways
to isolate HSC and multipotent progenitors [1,16,18,75–79].
Although populations isolated by alternative methods show
signiﬁcant overlap with the subsets described here, there is
likely even more complexity beyond the ones reported here.
For example, functionally distinct multipotent progenitors
can be separated based on CD4 and Mac1 expression [76], and
as these subsets express low levels of Thy1.1, they are likely
more primitive than the Thy1.1-negative MPP described here.
It is possible that the MPP we identiﬁed by Flk2 expression
are determined to respond to inﬂammatory stimuli. In
addition, since LT-HSC as deﬁned here can be divided into
two fractions by at least two different surface markers (Slamf1
and CD34), we anticipate that these and other novel antigens
will be useful in the ongoing reﬁnement of the relationship
between hematopoietic cell types and will increase our
understanding of cell fate decisions.
The relative quiescence of LT-HSC and stem cells of
nonhematopoietic lineages likely protects these cells from
exposure to reactive oxygen species and toxic metabolites
that could lead to DNA damage. Avoiding inheritable
damage would be particularly important for stem cells,
since they give rise to billions of mature cells throughout the
life of the host. Insults to the hematopoietic system could be
minimized if LT-HSC were resistant to cellular damage and
then capable of replacing the shorter-lived mature cells. In
addition to quiescence, the upregulation of transcripts
associated with cytoprotection such as p53, Ches1, Sesn1,
catalase, and Abcg2 in LT-HSC may play important roles in
maintaining the integrity of LT-HSC.
Importantly, Abcg2 and other ATP-binding cassette trans-
porters are associated with multidrug resistance of cancer
cells, and an important goal in cancer biology is to
understand the differences and similarities between normal
stem cells and cancer stem cells [80]. We recently identiﬁed
the leukemia-initiating cell fraction in a mouse model
resembling human chronic myelogenous leukemia (CML),
where the transplantable leukemia was contained in the
phenotypic LT-HSC compartment [81]. To understand the
molecular events leading to CML, we compared the
expression proﬁle of these leukemic HSC to normal HSC.
Many of the transcripts preferentially expressed by normal
LT-HSC are downregulated in the leukemic HSC (E.
Passegue ´, E. C. F., and I. L. W., unpublished data), emphasiz-
ing the importance of these genes in the regulation of
normal stem cells. We have also noted that in human CML
the leukemic stem cell is at the HSC stage during the early,
more indolent form of the disease, but when myeloid blast
crisis emerges the candidate leukemic stem cell is found in a
population of normally non-self-renewing cells [82]. In
addition to clarifying the events leading to neoplastic
transformation, understanding the similarities and differ-
ences between normal and oncogenic self-renewing cells will
help speciﬁc therapeutic targeting of cancer-initiating cells
while sparing normal HSC.
It is intriguing that many of the differentially regulated
transcripts represent components of functional units such as
receptor-ligand pairs and protein complexes as exempliﬁed
by the cell junction category (see Figure 4). Although some
of these molecules can be found at adherens junctions,
several are speciﬁcally associated with tight and gap
junctions. Roles for these types of junctions have not been
described in HSC; thus, determining their function will
provide novel insights to HSC biology. We are currently
assessing the functional role of Esam1 in hematopoiesis and
the use of this antigen as a highly selective marker for LT-
Figure 5. Schematic of Biological Processes that Gradually Decline or
Increase with LT-HSC Differentiation Based on the Relative Transcript
Levels Presented in this Report
Green circles represent LT-HSC, and color gradients from green to red
represent increasingly mature progeny.
DOI: 10.1371/journal.pgen.0010028.g005
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elsewhere.
The bone marrow microenvironment is crucial for adult
HSC regulation. However, in view of the number of
differentially expressed matrix molecules (i.e., Biglycan,
ApoE, collagens), homotypic-interacting proteins (i.e.,
Esam1, Mllt4, Slamf1, claudins, and connexins), and ligand-
receptor pairs (Angpt1:Tek, Slitl2:Robo4, Ccl3:Ccr5, and
IL1r1:IL1b) these cell populations seem surprisingly self-
sufﬁcient in controlling their fates. The importance of these
types of interactions for HSC function has been demon-
strated previously, for example between integrin a4b1 and
Vcam1, and between c-kit and SLF [14,83]. It should be
noted, however, that the simultaneous expression of inter-
acting molecules by the same cell presents cell biological
puzzles concerning the prevention or use of intermolecular
interactions and potential signaling during processing
through the endoplasmic reticulum, the Golgi, and post-
Golgi vesicles. Although other factors and cell types likely
play important roles, LT-HSC might be capable of modify-
ing their immediate environment by secreting matrix
molecules as well as ligands for surface receptors. The
abundance of homotypic-interacting surface molecules on
LT-HSC suggests that LT-HSC interact with cells expressing
at least some of the same molecules. Thus, it seems possible
that HSC interact with each other and that they may reside
in localized clusters in the bone marrow. The difﬁculty of
identifying functional HSC in their native environment
makes it even more challenging to determine what cell types
interact with HSC in situ. Our identiﬁcation of these novel
HSC surface proteins could support current evidence for
interactions between HSC and osteoblasts [10,11,62,84] and
facilitate the search for other cell types capable of
interacting with LT-HSC. In this regard, the expression of
some of the same molecules upregulated by LT-HSC
(biglycan, Gjb5, Slitl2) by AFT024 [85] may account for this
stromal line’s capability of supporting LT-HSC in culture for
several weeks [86].
Although interaction with the niche may be a prerequisite
for both HSC quiescence and self-renewal, these two
processes might be developmental choices since a truly
quiescent cell is not dividing. Thus, self-renewal requires
signals to proliferate, in combination with prevention of
apoptosis and differentiation. As many cell types are capable
of self-renewal, although for a limited time or number of
divisions, extended self-renewal may be regulated to a
greater extent by inhibition of differentiation than by active
promotion of self-renewal. The two main mechanisms
regulating LT-HSC properties could be location and
unresponsiveness to mitogenic and differentiation signals.
Proper localization of LT-HSC within the bone marrow
would be mediated by adhesion molecules preferentially
expressed by LT-HSC. This niche might be characterized by
high levels of molecules promoting quiescence and prevent-
ing differentiation, and by relatively low levels of signals
favoring proliferation and differentiation. LT-HSC may
contribute to the establishment of such gradients by
expressing ligands, protease inhibitors, and extracellular
matrix molecules, all of which would help retain the LT-
HSC in the niche, hiding from toxic metabolites and
mitogenic and differentiation signals (see Figure 5). We
propose that at the appropriate time, HSC are induced to
express relatively high levels of cyclin D3, which may enable
them to overcome the antiproliferative signals and allow LT-
HSC to undergo self-renewing divisions in the niche. More
extensive proliferation and differentiation may require cells
to move out of the niche. This might be facilitated by
enzymes that inhibit cell adhesion, such as heparanase and
metalloproteinases. Because MPP express higher levels of
these enzymes, as well as cytokines associated with more
differentiated cell types, some of this regulation could be
cell autonomous.
The second proposed major regulator of LT-HSC, relative
unresponsiveness to proliferation and differentiation sig-
nals, could be due to lack of receptors and signaling
molecules mediating such signals and by high levels of cell
cycle inhibitors. In contrast, ST-HSC and MPP may be
poised to move down a differentiation pathway, in part by
their inability to adhere to the niche, and in part by being
more responsive to differentiation and mitogenic signals
(Figure 5). Differentially expressed genes will cause two
different cells exposed to the same signals to respond
differently. For example, HSC with long-term repopulating
ability circulate in the blood under normal homeostatic
conditions [33], upon transplantation, and when induced to
mobilize. Thus, leaving the niche does not induce irrever-
sible differentiation in all cases. It is possible that passage
through the blood and reentry into the bone marrow allows
for stochastic relocation of cells to different kinds of
available niches, some that direct the cells to regain
quiescence, others to self-renew, or still others to differ-
entiate. Such a model also provides a means for LT-HSC to
sense and respond to homeostatic changes in the hema-
topoietic system more easily than if they remained in the
niche. Quiescence itself may contribute to the unresponsive-
ness of LT-HSC, since differentiation requires proliferation.
In addition, adhesion reinforces quiescence and vice versa,
creating a positive feedback loop.
As the deﬁnition of HSC currently depends mainly on
transplantation into irradiated hosts followed by assessment
of long-term multilineage readout, it is difﬁcult to deter-
mine to what extent an endogenous cell with a ST-HSC or
MPP cell surface phenotype self-renew normally as opposed
to upon transplantation. In addition, long-term engraftment
upon transplantation is dependent on cell cycle status, with
quiescent cells having higher engraftment potential (E.
Passegue ´, A. J. Wagers, and I. L. W., unpublished data)
[87,88]. The current transplantation-based deﬁnition of LT-
HSC is therefore directly tied to quiescence. When assayed
experimentally, long-term engraftment potential may thus
be more a measure of a cell’s ability to ﬁnd and then remain
in an environment supporting self-renewal divisions than a
measure of greater intrinsic ability to self-renew. Given this
perspective, it is not surprising to ﬁnd an abundance of
cell–cell and cell–matrix molecules on the surface of LT-
HSC. At this point, we can only speculate on the potential
implications of the novel LT-HSC-enriched transcripts.
However, the number and variety of adhesion molecules
we have identiﬁed as upregulated on LT-HSC support an
important role for such molecules in LT-HSC function. In
addition, the types of cell surface molecules identiﬁed in
this report allow for dynamic regulation, since several
receptors are regulated by soluble ligands and proteases,
and recent literature has provided convincing evidence for
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et al. proposed that Tek actively promotes adhesion and
quiescence when bound by its ligand angiopoietin1 [12], and
Mmps facilitate HSC differentiation by facilitating exit from
the niche [13]. Our data support these reports and reveal
numerous additional candidates that are likely to participate
in dynamically regulated niche-cell interactions. Clearly, LT-
HSC express genes that enable them to participate in
complex cell–cell and cell–matrix interactions that direct
their function and developmental decisions. These and
other differentially expressed transcripts allowed us to
generate a model that will guide our current functional
approaches to understand HSC biology.
Materials and Methods
Isolation of cells. LT-HSC (Lin
 /c-kit
þ/Sca1
þ/Thy1.1
lo/Flk2
 ), ST-
HSC (Lin
 /c-kit
þ/Sca1
þ/Thy1.1
lo/Flk2
þ), and MPP (Lin
 /c-kit
þ/Sca1
þ/
Thy1.1
 /Flk2
þ) were isolated from bone marrow of 8- to 12-wk-old BA
mice by double-sorting on a modiﬁed FACS Vantage (Becton-
Dickinson, Mountain View, California, United States) as described
[16]. Appropriate functional readout was conﬁrmed by transplanta-
tion into lethally irradiated hosts (unpublished data).
RNA isolation, ampliﬁcation, and labeling for array analysis. Cells
from individual isolations were pooled into 30,000- to 50,000-cell
aliquots and RNA was extracted by Trizol. DNaseI treated RNA was
ampliﬁed in two rounds by Arcturus RNA ampliﬁcation kit following
instructions from the manufacturer (Arcturus, Mountain View,
California, United States). Ampliﬁed RNA (2.5 lg) was reverse
transcribed with amino-allyl labeled deoxynucleotides (Ambion,
Austin, Texas, United States) and dye-labeled by incubation with
Cy3 or Cy5 for 1 h (http://cmgm.stanford.edu/pbrown/protocols/index.
html). Probes were combined for the appropriate comparisons,
puriﬁed with QiaQuick PCR puriﬁcation kit (Qiagen, Valencia,
California, United States) and eluted twice with 30 ll of EB. In each
experiment, all probes were labeled by both Cy3 and Cy5 in separate
reactions and combined with its comparison partner labeled in the
other color in ‘‘dye-swap’’ experiments to eliminate bias due to
differences in dye labeling efﬁciency. Volumes were adjusted to 28 ll
by vacuum centrifugation and brought to 35 ll with a ﬁnal
concentration of 0.3% SDS and 3.43 SSC.
cDNA array hybridization. Competitive hybridizations on Stanford
Microarray Facility 42k mouse cDNA arrays (http://www.microarray.
org) were performed in three independent experiments, each time in
duplicate to accommodate ‘‘dye swaps,’’ for a total of six hybrid-
izations for each pairwise comparison. Combined probes were
denatured and layered on Stanford cDNA microarray slides, cover-
slipped, and placed in sealed, humidiﬁed chambers in a 65 8C
waterbath overnight (12–16 h). Slides were washed in 0.53 SSC with
0.01%SDS for 5 min and 0.063 SSC for 2 min. Slides were scanned
with a Genepix 4000A scanner using GenepixPro software. Care was
taken to match Cy3 and Cy5 emission spectra during scanning.
Data analysis. Scanned images were gridded with GenepixPro.
‘‘Bad’’ or missing spots were ﬂagged by the software as well as visually.
Resulting ﬁles were submitted to the Stanford Microarray Database
(http://genome-www.stanford.edu/microarray) to assign identity to
each spot and to normalize Cy3/Cy5 relative intensities for each slide.
The log2 net intensity ratios were print-tip normalized (see below).
Type I hybridizations directly comparing two different populations
on the same array and therefore under exactly the same conditions
enables a highly sensitive detection of differences between two
populations without normalizing to a common reference that may
vary from sample to sample. To further enable detection of the small,
but potentially biologically highly signiﬁcant, differences between the
small developmental steps our three populations represent, no ﬁlters
for intensity levels or spot size and shape were applied. Instead, our
most stringent criterion was reproducibility. Six hybridizations in
three independent experiments were performed for each pairwise
comparison, and spots had to be present (not ﬂagged as undetectable
or bad) on at least ﬁve out of the six pairwise comparisons. Spots
passing this criterion were analyzed for statistically signiﬁcant
differences using Signiﬁcance Analysis of Microarrays (SAM; http://
www-stat.stanford.edu/;tibs/SAM/) [89]. Because some genes were
represented by multiple spots, each list was ﬁltered by Unigene ID,
clone ID, and GenBank accession number to determine the number
of unique genes in each list. The number of spots and transcripts
resulting from these analyses are summarized in Table 1. Signiﬁcantly
differentially regulated genes as deﬁned by SAM at a false discovery
rate of 10% are listed in Tables S1–S6.
Print tip normalization. Chip- or dye-speciﬁc biases were corrected
for by applying print-tip loess using the BioConductor R package to
all log-ratios. First, spots with intensity signals indistinguishable from
background were ﬁltered out. To achieve high signal-to-noise, any
spot with average foreground intensity within 10% of the average
background level was ﬂagged as absent. Within each print-tip group,
the mean and standard deviation of the log-ratios were computed
within a window of values for the log-product. The log-ratios within
this window were then centered and scaled using the estimated mean
and standard deviation. This was applied to each window and
repeated across all print tips.
Gene Ontology (GO) analysis. GO classiﬁcation and statistics were
performed using GOstat (http://gostat.wehi.edu.au/) and eGOn (http://
nova2.idi.ntnu.no/egon/) with similar results. Genes upregulated in
the less differentiated cell type of each comparison were combined to
make an ‘‘undifferentiated’’ list (genes up in LT-HSC compared to
either ST-HSC or MPP and genes up in ST-HSC compared to MPP).
The ‘‘differentiated’’ list was made by combining genes upregulated
in the more differentiated cell type (genes up in MPP versus either
ST-HSC or LT-HSC, and genes up in ST-HSC versus LT-HSC).
Similar results were obtained when genes upregulated and down-
regulated in the ‘‘LTvsMPP’’ comparison were used as the only input.
Real-time RT-PCR. Total RNA was isolated using Trizol reagent
(Invitrogen, Carlsbad, California, United States) from equal numbers
of puriﬁed LT-HSC, ST-HSC, and MPP (typically 8,000 10,000 cells),
digested with DNaseI, and used for reverse transcription according to
the manufacturer’s instructions (SuperScript II kit, Invitrogen). For
qRT-PCR analysis, primer sequences were designed using Primer
Express software (Applied Biosystems, Foster City, California, United
States) and are available upon request. PCR ampliﬁcation was
performed in triplicate in a 10 ll ﬁnal volume containing cDNA
corresponding to approximately 200 cells, and 13 SYBR Green PCR
buffer, 2 mM magnesium chloride, 0.5 mM dNTP mix with dUTP, 1
lM of each primer, 0.1 U AmpErase UNG, and 0.25 U AmpliTaq
Gold. All reactions were performed in an ABI-7000 sequence
detection system (Applied Biosystems) at 50 8C for 2 min and 95 8C
for 10 min followed by 40 cycles at 95 8C for 15 s and 60 8C for 1 min.
For each sample, expression of the HPRT gene was used to normalize
the amount of the investigated transcript.
Cell surface protein levels by ﬂow cytometry. Cell surface protein
expression was assessed by staining for LT-HSC, ST-HSC, and MPP
with antibodies as described above, except an additional color was
used (Cy7PE) to accommodate the additional antigen. Antibodies
used were aVCAM1-biotin (eBioscience, San Diego, California,
United States; clone #429), aCD9-biotin (BD Pharmingen, San Diego,
California, United States; #KMC8), aSdc1-biotin (BD Pharmingen;
#281–2), aESAM1 (clones 4G8 and 3C10) [25] conjugated to Alexa488,
aSlamf1-PE (BioLegend, San Diego, California, United States; #TC15-
12F12.2), aCD34-FITC (BD Pharmingen; #RAM34), aTek-biotin
(eBioscience; #Tek4), and aJam2-FITC (SeroTec, Kidlington, Oxford,
United Kingdom; #CRAM-18 F26).
Large-scale cDNA microarrays similar to the ones used for this
study are available to researchers at not-for-proﬁt research institu-
tions by contacting the Stanford Functional Genomics Facility, CCSR
4256, 269 Campus Drive, Stanford, CA 94305-5177, United States, or
by visiting http://www.microarray.org.
Supporting Information
Figure S1. Quantitative RT-PCR of a Subset of Transcripts Identiﬁed
as Differentially Regulated by Array Analysis
Transcript levels are plotted as fold difference relative to LT-HSC
after normalization to HPRT transcript levels. Blue bars represent
ST-HSC and red bars represent MPP. Fold difference for genes off
scale: Grb10, 103; Nupr1, 293; Sdc2, 623; and Tgm2, 373.
Found at DOI: 10.1371/journal.pgen.0010028.sg001 (554 KB PDF).
Figure S2. Chromosomal Distribution of Genes Differentially
Regulated Between LT-HSC and MPP
The distribution of genes that are differentially regulated between
LT-HSC (green) and MPP (red) were normalized to total number of
differentially regulated genes with known chromosomal location for
each population.
Found at DOI: 10.1371/journal.pgen.0010028.sg002 (71 KB PDF).
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Novel Hematopoietic Stem Cell RegulatorsTable S1. Transcripts Upregulated in ST-HSC Compared to LT-HSC
Found at DOI: 10.1371/journal.pgen.0010028.st001 (181 KB XLS).
Table S2. Transcripts Upregulated in LT-HSC Compared to ST-HSC
Found at DOI: 10.1371/journal.pgen.0010028.st002 (99 KB XLS).
Table S3. Transcripts Upregulated in MPP Compared to LT-HSC
Found at DOI: 10.1371/journal.pgen.0010028.st003 (160 KB XLS).
Table S4. Transcripts Upregulated in LT-HSC Compared to MPP
Found at DOI: 10.1371/journal.pgen.0010028.st004 (260 KB XLS).
Table S5. Transcripts Upregulated in MPP Compared to ST-HSC
Found at DOI: 10.1371/journal.pgen.0010028.st005 (18 KB XLS).
Table S6. Transcripts Upregulated in ST-HSC Compared to MPP
Found at DOI: 10.1371/journal.pgen.0010028.st006 (53 KB XLS).
Table S7. Transcripts Upregulated in LT-HSC Mapped to the X
Chromosome
Found at DOI: 10.1371/journal.pgen.0010028.st007 (32 KB XLS).
Table S8. Additional References
Found at DOI: 10.1371/journal.pgen.0010028.st008 (52 KB XLS).
Accession Numbers
The LocusLink accession numbers (LLIDs) (http://www.ncbi.nlm.nih.
gov/projects/LocusLink/) of the proteins discussed in this paper are
4a2 (12827), Abcg2 (26357), Aldh1a1 (11668), Aldh7a1 (110695),
angiopoietin 1 (11600), ApoE (11816), App (11820), Atrx (22589),
biglycan (12111), Blnk (17060), Calsyntenin1 (65945), catalase (12359),
Ccl3 (20302), Ccl4 (20304), Ccl9 (20308), Ccr5 (12774), CD34 (12490),
CD63 (12512), CD9 (12527), Cenpe (229841), Cenph (26886), Ches1
(71375), Claudin12 (64945), Claudin22 (75677), c-myc (17869),
collagens type 4a1 (12826), cortactin (13043), cyclin A2 (12428),
cyclin B1 (268697), cyclin B2 (12442), cyclin D1 (12443), cyclin D3
(12445), Cyp2j6 (13110), Dachshund1 (13134), Dag1/dystroglycan
(13138), Ddx4 (13206), Emilin1 (100952), Epb4.1 (269587), ESAM1
(69524), Eya2 (14049), Fgd1 (14163), Fstl1 (14314), Gata1 (14460),
Gata2 (14461), Gelsolin (227753), Gja1 (14609), Gjb5 (14622), Grb10
(14783), Grb2 (14784), Gsta1 (14857), Gstk1 (76263), Gstm1 (14862),
heparanase (15442), Hmgb3 (15354), Hoxa5 (15402), Hoxa9 (15405),
Hoxb5 (15413), Ier5 (15939), Igh6 (16019), IL1b (16176), IL10ra
(16154), IL10rb (16155), IL17r (16172), IL1r1 (16177), Itga6 (16403),
Jam1/F11R (16456), Jam2 (67374), Jam3 (83964), Ki67 (17345), Kif22
(110033), Kif23 (71819), Kif4 (16571), Kifc5a (94116), Lims1 (110829),
Map17 (67182), Mllt4 (17356), Mlp (17357), Mmp15 (17388), Mmp16
(17389), Mmp2 (17390), Mpeg1 (17476), necdin (17984), Neogenin
(18007), Nfe2 (18022), Notch1 (18128), Notch1 (18128), p53 (22059),
p57/Cdkn1c (12577), Pbx1 (18514), Pbx3 (18516), Robo4 (74144),
sarcoglycanE (20392), Satb1 (20230), Sdc1 (20969), Sdc2 (15529), Sesn1
(140742), Ski (20481), Slamf1 (27218), Slit-like2 (246154), Smc1l1
(24061), Smc2l1 (14211), Smc4l1 (70099), Sox18 (20672), Sox6 (20679),
Spag5 (54141), Srgap2 (14270), Tcf12 (21406), Tek (21687), Tgm2
(21817), Timp2 (21858), Timp3 (21859), Tjp1/ZO-1 (21872), Top2a
(21973), and VCAM1 (22329).
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